Oct 11 (Reuters) - Critical Outcome Technologies Inc COT.V :
* CRITICAL OUTCOME TECHNOLOGIES ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 TRIAL OF COTI-2 IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
* CRITICAL OUTCOME TECHNOLOGIES - TOP-LINE DATA OF COTI-2 IN HEAD AND NECK SQUAMOUS CELL CARCINOMA EXPECTED IN 2018
* CRITICAL OUTCOME TECHNOLOGIES INC - REMAIN ON TRACK TO ANNOUNCE SECONDARY AND EXPLORATORY ENDPOINT DATA OF COTI-2 BY YEAR-END